ANEW - ETF AI Analysis

Top Page

ProShares MSCI Transformational Changes ETF (ANEW)

Rating:63Neutral

Price Target:$58.00▲(6.11% Upside)

Positive Factors

Broad Sector DiversificationThe ETF spreads its investments across many sectors like health care, technology, communication services, and consumer stocks, which helps reduce the impact if one industry struggles.

Solid Recent PerformanceThe fund has shown steady gains over the past month, three months, and year to date, indicating positive recent momentum.

Strong Health Care and Tech LeadersSeveral top holdings in health care and technology, such as Eli Lilly, AbbVie, Apple, and others, have delivered strong year-to-date performance that supports the fund’s returns.

Negative Factors

Small Asset BaseThe ETF manages a relatively low amount of assets, which can make it more vulnerable to large investor inflows or outflows and potentially higher trading spreads.

Mixed Performance Among Top HoldingsSome of the largest positions, including DoorDash, Abbott Laboratories, McCormick, and Meta Platforms, have shown weak year-to-date performance, which can drag on overall results.

Heavy U.S. ConcentrationWith most of its holdings in U.S. companies, the fund is heavily tied to the U.S. market and offers limited protection if that market faces a downturn.

ANEW vs. SPDR S&P 500 ETF (SPY)

AUM: 8.23M
Region: Global
Expense Ratio: 0.45%
Beta: 0.93
Issuer: ProShares
Inception Date: Oct 14, 2020
Dividend Yield: 0.48%
Asset Class: Equity
Index Tracked: MSCI Global Transformational Changes Index

ANEW Summary

ANEW is an ETF that follows the MSCI Global Transformational Changes Index, focusing on big long-term themes like new technology, aging populations, and environmental change. It holds a mix of health care, technology, and communication companies from around the world, including well-known names like Apple and Meta Platforms, as well as major drug makers such as AbbVie and Eli Lilly. Someone might invest in ANEW to get diversified exposure to companies driving future growth and innovation in many industries at once. A key risk is that these growth-focused stocks can be volatile and may go up and down sharply with market conditions.

How much will it cost me?

The ProShares MSCI Transformational Changes ETF (Ticker: ANEW) has an expense ratio of 0.45%, which means you’ll pay $4.50 per year for every $1,000 invested. This expense ratio is slightly higher than average because the fund is actively managed to focus on companies driving transformational changes across industries, requiring more research and specialized management.

What would affect this ETF?

The ANEW ETF could benefit from continued advancements in technology, healthcare innovation, and global adoption of clean energy solutions, as these sectors are heavily represented in its holdings. However, it may face challenges from rising interest rates, which can impact growth-focused companies, and regulatory changes in key markets like China, where some top holdings are based. Global economic uncertainty could also affect consumer spending and corporate investments in transformational industries.

ANEW Top 10 Holdings

ANEW is leaning heavily into health care innovators, with Moderna and Eli Lilly acting as key engines of recent gains as their drug and vaccine pipelines stay in the spotlight. AbbVie and Danaher add steady, if less exciting, support from the same sector. On the tech side, Microsoft and Meta give the fund a Big Tech backbone, though Microsoft’s momentum has cooled a bit and Meta’s run has been strong but choppy. With a global mix that includes European names like Symrise and Givaudan, the ETF is diversified geographically but thematically concentrated in future-focused medicine and technology.

ANEW top ten holdings
Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
MRNA	Moderna	2.64%	$216.52K	$90.58B	772.32%	59Neutral
DHR	Danaher	2.50%	$205.27K	$157.77B	7.35%	75Outperform
ABBV	AbbVie	2.48%	$203.81K	$499.53B	23.13%	66Neutral
MSFT	Microsoft	2.44%	$200.77K	$3.96T	3.88%	79Outperform
DASH	DoorDash	2.37%	$194.82K	$83.86B	-26.43%	76Outperform
META	Meta Platforms	2.32%	$190.94K	$1.80T	-1.60%	76Outperform
IFF	International Flavors & Fragrances	2.23%	$183.00K	$23.21B	42.68%	61Neutral
LLY	Eli Lilly & Co	2.19%	$179.76K	$1.17T	54.50%	72Outperform
CH:GIVN	Givaudan SA	2.19%	$179.68K	CHF 36.61B	11.12%	69Neutral
DE:SY1	Symrise	2.17%	$178.29K	EUR 14.08B	26.25%	63Neutral

ANEW Technical Analysis

Technical Analysis SentimentPositive

Last Price54.66

Price Trends

50DMA54.18Positive

100DMA52.70Positive

200DMA50.67Positive

Market Momentum

MACD0.19Negative

RSI55.66Neutral

STOCH95.92Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ANEW, the sentiment is Positive. The current price of 54.66 is above the 20-day moving average (MA) of 54.48, above the 50-day MA of 54.18, and above the 200-day MA of 50.67, indicating a bullish trend. The MACD of 0.19 indicates Negative momentum. The RSI at 55.66 is Neutral, neither overbought nor oversold. The STOCH value of 95.92 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ANEW.

ANEW Peer Comparison

Comparison Results

ANEW against its peer funds
Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
ANEW	$54.66	$58.00(6.11% Upside)	$8.23M	0.45%	63Neutral
FFND	$31.77	$39.02(22.82% Upside)	$95.19M	0.98%	69Neutral
NXTE	$43.86	$61.14(39.40% Upside)	$47.68M	1.00%	55Neutral
DARP	$55.77	$75.17(34.78% Upside)	$40.77M	0.75%	71Outperform
FIZY	$25.93	$31.47(21.37% Upside)	$13.13M	1.01%	71Outperform
GAIQ	$64.25	$79.00(22.96% Upside)	$642.00K	0.79%	75Outperform

Performance Comparison

ANEW and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
ANEW	ProShares MSCI Transformational Changes ETF	54.66	2.89	5.59%
FFND	Future Fund Active ETF	31.77	1.92	6.43%
NXTE	AXS Green Alpha ETF	43.86	3.61	8.97%
DARP	Grizzle Growth Etf	55.77	13.55	32.10%
FIZY	Fitz-Gerald Must Have Portfolio and Options Overlay ETF	25.93	0.66	2.61%
GAIQ	Guinness Atkinson Global Innovators Fund: ETF Class Shares	64.25	-0.61	-0.94%

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.